Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
5.04
-0.21 (-4.00%)
Mar 12, 2026, 2:08 PM EDT - Market open
Bicycle Therapeutics Market Cap
Bicycle Therapeutics has a market cap or net worth of $349.61 million as of March 12, 2026. Its market cap has decreased by -54.49% in one year.
Market Cap
349.61M
Enterprise Value
-294.36M
1-Year Change
-54.49%
Ranking
Category
Stock Price
$5.04
Market Cap Chart
Since May 23, 2019, Bicycle Therapeutics's market cap has increased from $212.36M to $349.61M, an increase of 64.64%. That is a compound annual growth rate of 7.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 364.18M | -25.85% |
| Dec 31, 2025 | 491.12M | -49.19% |
| Dec 31, 2024 | 966.64M | 26.03% |
| Dec 29, 2023 | 766.98M | -12.72% |
| Dec 30, 2022 | 878.81M | -50.89% |
| Dec 31, 2021 | 1.79B | 367.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| X4 Pharmaceuticals | 378.60M |
| LENZ Therapeutics | 376.11M |
| Candel Therapeutics | 373.56M |
| NovaBridge Biosciences | 371.24M |
| Absci | 368.41M |
| Greenwich LifeSciences | 368.12M |
| Immuneering | 365.29M |
| Aura Biosciences | 360.06M |